WESTFORD, Mass., Nov. 9, 2015 /PRNewswire/ -- Cynosure, Inc. (NASDAQ: CYNO), which develops and markets laser- and light-based aesthetic treatment systems for high-volume applications, today announced that Chairman and Chief Executive Officer Michael Davin and Tim Baker, the Company’s President and Chief Financial Officer, will be participating in two upcoming investor conferences:
- Brean Capital 2015 Life Science Summit on Monday, November 16 at the Millennium Broadway Hotel in New York City.
- Stifel Healthcare Conference on Tuesday, November 17 at 10:15 a.m. (ET) at The New York Palace Hotel in New York City. This will be a fireside chat format.
A live audio webcast of the Stifel presentation will be available on the “Investor Relations” section of the Company’s website at www.cynosure.com. An archived presentation will be available for 90 days.
About Cynosure, Inc.
Cynosure develops, manufactures, and markets aesthetic treatment systems that enable plastic surgeons, dermatologists and other medical practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, reduce fat through non-invasive and minimally invasive laser lipolysis, reduce cellulite, clear nails infected by toe fungus, ablate sweat glands and improve vaginal health. Cynosure also markets radiofrequency energy-sourced medical devices for precision surgical applications such as facial plastic and general surgery, gynecology, ear, nose, and throat procedures, ophthalmology, oral and maxillofacial surgery, podiatry and proctology. Cynosure’s product portfolio is composed of a broad range of energy sources including Alexandrite, diode, Nd:YAG, picosecond, pulse dye, Q-switched lasers, intense pulsed light and radiofrequency technology. Cynosure sells its products globally under the Cynosure, Palomar, ConBio and Ellman brand names through a direct sales force in the United States, Canada, Mexico, France, Morocco, Germany, Spain, the United Kingdom, Australia, China, Japan and Korea, and through international distributors in approximately 120 other countries. For corporate or product information, visit Cynosure’s website at www.cynosure.com.
Contact:
Scott Solomon
Senior Vice President
Sharon Merrill Associates, Inc.
617.542.5300
cyno@investorrelations.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cynosure-to-participate-in-upcoming-investor-conferences-300174696.html
SOURCE Cynosure, Inc.
Help employers find you! Check out all the jobs and post your resume.
